For years now, scientists have tried to develop a safe and effective dengue vaccine. The challenge however, is that there are ...

Japan-based Takeda Pharmaceuticals, manufacturer of the second-generation dengue vaccine Qdenga, said it is just waiting for ...

ICMR and Panacea Biotec aim to finish enrollment for Phase 3 trials of India’s first indigenous dengue vaccine by October ...

As summer ushers in peak mosquito season, health and vector control officials are bracing for the possibility of another year ...

Although general awareness about dengue has improved, according to experts, a significant portion of the population remains ...

Takeda Healthcare Philippines on Thursday said that its voluntary withdrawal of its dengue applications in the US and Singapore has something to do with requested ...

As summer ushers in peak mosquito season, health and vector control officials are bracing for the possibility of another year ...

In a significant development that could reshape India’s battle against dengue fever, the country is inching closer to unveiling its first homegrown dengue vaccine. With the Phase-3 trial enrolment for ...

The QDenga vaccine is an live-attenuated vaccine with an 80% first year post-vaccination efficacy against Virologically Confirmed Dengue (VCD) fever, recommended for prevention of the disease in ...